Correlation Between Bristol Myers and Evolus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Evolus Inc, you can compare the effects of market volatilities on Bristol Myers and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Evolus.

Diversification Opportunities for Bristol Myers and Evolus

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Bristol and Evolus is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Bristol Myers i.e., Bristol Myers and Evolus go up and down completely randomly.

Pair Corralation between Bristol Myers and Evolus

Considering the 90-day investment horizon Bristol Myers is expected to generate 5.18 times less return on investment than Evolus. But when comparing it to its historical volatility, Bristol Myers Squibb is 5.47 times less risky than Evolus. It trades about 0.22 of its potential returns per unit of risk. Evolus Inc is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  1,104  in Evolus Inc on November 1, 2024 and sell it today you would earn a total of  317.00  from holding Evolus Inc or generate 28.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Evolus Inc

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Evolus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Bristol Myers and Evolus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Evolus

The main advantage of trading using opposite Bristol Myers and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.
The idea behind Bristol Myers Squibb and Evolus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency